Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - STOCK-BASED COMPENSATION
Stock-based Compensation REGN - Regeneron Pharmaceuticals, Inc.
983 M
LAST VALUE
16.43%
2 YEAR CAGR
16.18%
5 YEAR CAGR
12.33%
10 YEAR CAGR